Timeline
More in Pharma
Convatec confirms guidance, launches $200m buyback
"We are on track for another year of margin expansion and double-digit EPS growth", said chief executive Jonny Mason
"We are on track for another year of margin expansion and double-digit EPS growth", said chief executive Jonny Mason